1. Home
  2. NURO
  3. NURO News

Latest NeuroMetrix Inc. (NURO) News on December 18, 2024

NURO

MT Newswires

a day ago

electroCore to Acquire NeuroMetrix to Become Diversified Player in Non-Invasive Wellness Treatments

NeuroMetrix to be Acquired by electroCore
NURO

GlobeNewswire

a day ago

NeuroMetrix to be Acquired by electroCore

NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth
NURO

Zacks

a month ago

NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth

NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023)
NURO

Simply Wall St.

a month ago

NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023)

NeuroMetrix Reports Q3 2024 Business Highlights
NURO

GlobeNewswire

a month ago

NeuroMetrix Reports Q3 2024 Business Highlights

NURO

MT Newswires

4 months ago

NeuroMetrix Finds No Viable Transactions in Strategic Review

NeuroMetrix Reiterates its Review of Strategic Alternatives
NURO

GlobeNewswire

4 months ago

NeuroMetrix Reiterates its Review of Strategic Alternatives

NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023)
NURO

Simply Wall St.

4 months ago

NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023)

NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options
NURO

GlobeNewswire

4 months ago

NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options

NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call
NURO

GlobeNewswire

5 months ago

NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call

NeuroMetrix Reports Q1 2024 Business Highlights
NURO

GlobeNewswire

7 months ago

NeuroMetrix Reports Q1 2024 Business Highlights

NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year
NURO

Simply Wall St.

8 months ago

NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
NURO

GlobeNewswire

8 months ago

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
NURO

GlobeNewswire

9 months ago

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
NURO

GlobeNewswire

9 months ago

NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia

NURO

ACCESSWIRE

9 months ago

Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired

NURO

ACCESSWIRE

9 months ago

RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.

NURO

ACCESSWIRE

9 months ago

Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.

NeuroMetrix Full Year 2023 Earnings: US$6.08 loss per share (vs US$4.96 loss in FY 2022)
NURO

Simply Wall St.

10 months ago

NeuroMetrix Full Year 2023 Earnings: US$6.08 loss per share (vs US$4.96 loss in FY 2022)

NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript
NURO

Insider Monkey

10 months ago

NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript

NURO

Thomson Reuters StreetEvents

10 months ago

Q4 2023 NeuroMetrix Inc Earnings Call

NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
NURO

GlobeNewswire

10 months ago

NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
NURO

GlobeNewswire

10 months ago

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call

NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
NURO

GlobeNewswire

10 months ago

NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value

Trinity Biotech Announces Q3 2023 Financial Results & Business Update
NURO

GlobeNewswire

a year ago

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
NURO

GlobeNewswire

a year ago

Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.

Intelligent Product Solutions Names Jan Niewiadomski to CTO
NURO

GlobeNewswire

a year ago

Intelligent Product Solutions Names Jan Niewiadomski to CTO

Alegeus CEO, Leif O’Leary & Aeries Technology COO (Americas) & CRO, Ajay Khare on the Mid-Market Tech Industry & Need for a Global Workforce
NURO

Exec Edge

a year ago

Alegeus CEO, Leif O’Leary & Aeries Technology COO (Americas) & CRO, Ajay Khare on the Mid-Market Tech Industry & Need for a Global Workforce

LED Lighting, EV Charging and Maintenance Solutions Provider Orion Hosts Q3 Call Wed., February 7th at 10am ET
NURO

GlobeNewswire

a year ago

LED Lighting, EV Charging and Maintenance Solutions Provider Orion Hosts Q3 Call Wed., February 7th at 10am ET

CENTOGENE Receives French Research Tax Credit Accreditation
NURO

GlobeNewswire

a year ago

CENTOGENE Receives French Research Tax Credit Accreditation

U Power Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
NURO

GlobeNewswire

a year ago

U Power Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601
NURO

GlobeNewswire

a year ago

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
NURO

PR Newswire

a year ago

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium

Orion (OESX) Preliminary Q3 Results Depict Strong Demand
NURO

Zacks

a year ago

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model
NURO

Business Wire

a year ago

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model

Reborn Coffee to Conduct 1-for-8 Reverse Stock Split
NURO

GlobeNewswire

a year ago

Reborn Coffee to Conduct 1-for-8 Reverse Stock Split

DecisionPoint (DPSI) Unveils PointCare to Offer Tech Services
NURO

Zacks

a year ago

DecisionPoint (DPSI) Unveils PointCare to Offer Tech Services

NURO

Business Wire

a year ago

VIA optronics AG Announces Receipt of Notice Regarding NYSE Continued Listing Standards

NURO

Reuters

a year ago

Grain producer YanGuFang's CEO, CFO detained in China

YanGuFang Provides Update on Its CEO and CFO and Operations
NURO

GlobeNewswire

a year ago

YanGuFang Provides Update on Its CEO and CFO and Operations

LightPath Announces Upcoming Conference Participation
NURO

ACCESSWIRE

a year ago

LightPath Announces Upcoming Conference Participation

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients
NURO

GlobeNewswire

a year ago

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting
NURO

GlobeNewswire

a year ago

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now
NURO

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now

NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
NURO

GlobeNewswire

a year ago

NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024

Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
NURO

PR Newswire

a year ago

Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12

NURO

Business Wire

a year ago

Vince Announces Participation in the 26th Annual ICR Conference

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences
NURO

GlobeNewswire

a year ago

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences

Cepton, Inc. Confirms Receipt of Indication of Interest From Koito Manufacturing Co., Ltd.
NURO

Business Wire

a year ago

Cepton, Inc. Confirms Receipt of Indication of Interest From Koito Manufacturing Co., Ltd.

GEE Group, Inc. (AMEX:JOB) Q4 2023 Earnings Call Transcript
NURO

Insider Monkey

a year ago

GEE Group, Inc. (AMEX:JOB) Q4 2023 Earnings Call Transcript

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension
NURO

GlobeNewswire

a year ago

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension

EXCLUSIVE: La Rosa Acquires Majority Stake In Fourth Real Estate Brokerage Franchisee
NURO

Benzinga

a year ago

EXCLUSIVE: La Rosa Acquires Majority Stake In Fourth Real Estate Brokerage Franchisee

La Rosa Acquires Fourth Real Estate Brokerage Franchisee with Revenue of $2.7 Million and Positive Net Income in 2022
NURO

GlobeNewswire

a year ago

La Rosa Acquires Fourth Real Estate Brokerage Franchisee with Revenue of $2.7 Million and Positive Net Income in 2022

NURO

Thomson Reuters StreetEvents

a year ago

Q4 2023 GEE Group Inc Earnings Call

Mary Ann Halford Appointed to Cineverse Board of Directors
NURO

PR Newswire

a year ago

Mary Ann Halford Appointed to Cineverse Board of Directors

GEE Group Announces Results for the Fiscal 2023 Full Year and Fourth Quarter
NURO

ACCESSWIRE

a year ago

GEE Group Announces Results for the Fiscal 2023 Full Year and Fourth Quarter

NURO

GlobeNewswire

a year ago

YanGuFang Oatmeal Tops Sales Chart in Key Category on Douyin during the Double 11 Festival in China

NURO

Newsfile

a year ago

Cannell Capital Demands Board Refresh at VIA Optronics

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
NURO

GlobeNewswire

a year ago

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer
NURO

GlobeNewswire

a year ago

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer

NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)
NURO

GlobeNewswire

a year ago

NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)

LightPath Announces Initial $4.7m Order from Lockheed Martin
NURO

ACCESSWIRE

a year ago

LightPath Announces Initial $4.7m Order from Lockheed Martin

IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
NURO

GlobeNewswire

a year ago

IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement

OptimumBank Holdings, Inc. (OPHC-NASDAQ) Chairman Gubin’s comments pertaining to the Board’s Strategic Planning - “A successful roadmap for growing our Bank”
NURO

GlobeNewswire

a year ago

OptimumBank Holdings, Inc. (OPHC-NASDAQ) Chairman Gubin’s comments pertaining to the Board’s Strategic Planning - “A successful roadmap for growing our Bank”

Vince Holding Corp. (NYSE:VNCE) Q3 2023 Earnings Call Transcript
NURO

Insider Monkey

a year ago

Vince Holding Corp. (NYSE:VNCE) Q3 2023 Earnings Call Transcript

Secure Medical Chooses Edgio for Fast, Secure Delivery of Telehealth Services
NURO

Business Wire

a year ago

Secure Medical Chooses Edgio for Fast, Secure Delivery of Telehealth Services

Univest Securities, LLC Announces Closing of $12 Million Registered Follow-on Offering for its Client U Power Limited. (Nasdaq: UCAR)
NURO

GlobeNewswire

a year ago

Univest Securities, LLC Announces Closing of $12 Million Registered Follow-on Offering for its Client U Power Limited. (Nasdaq: UCAR)

U Power Limited Announces Closing of Registered Follow-on Offering
NURO

GlobeNewswire

a year ago

U Power Limited Announces Closing of Registered Follow-on Offering

NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)
NURO

GlobeNewswire

a year ago

NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)

NURO

Business Wire

a year ago

VIA optronics Provides Further Update to Recent Management Communications

Abercrombie & Fitch CEO: A leadership master class on saving a retail icon
NURO

Yahoo Finance

a year ago

Abercrombie & Fitch CEO: A leadership master class on saving a retail icon

Abercrombie & Fitch CEO’s turnaround playbook: Lead This Way premiere
NURO

Yahoo Finance Video

a year ago

Abercrombie & Fitch CEO’s turnaround playbook: Lead This Way premiere

Express (EXPR) Q3 2023 Earnings Call Transcript
NURO

Motley Fool

a year ago

Express (EXPR) Q3 2023 Earnings Call Transcript

Express CEO acknowledges merchandising missteps
NURO

Retail Dive

a year ago

Express CEO acknowledges merchandising missteps

NURO

Newsfile

a year ago

"Rescue VIAO" Has Been Formed to Help All Injured Shareholders of VIA Optronics AG (VIAO)

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Ovarian Cancer
NURO

GlobeNewswire

a year ago

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Ovarian Cancer

YanGuFang Expands Retail Presence in China's Supermarkets
NURO

GlobeNewswire

a year ago

YanGuFang Expands Retail Presence in China's Supermarkets

NeuroMetrix Announces One-for-Eight Reverse Stock Split
NURO

GlobeNewswire

a year ago

NeuroMetrix Announces One-for-Eight Reverse Stock Split

NURO

Business Wire

a year ago

VIA optronics Provides Corporate and Management Updates

TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) Q3 2023 Earnings Call Transcript
NURO

Insider Monkey

a year ago

TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) Q3 2023 Earnings Call Transcript

The Market Doesn't Like What It Sees From Dragonfly Energy Holdings Corp.'s (NASDAQ:DFLI) Revenues Yet As Shares Tumble 60%
NURO

Simply Wall St.

a year ago

The Market Doesn't Like What It Sees From Dragonfly Energy Holdings Corp.'s (NASDAQ:DFLI) Revenues Yet As Shares Tumble 60%

Tomi Environmental Solutions, Inc. Reports Third Quarter Financial Results
NURO

GlobeNewswire

a year ago

Tomi Environmental Solutions, Inc. Reports Third Quarter Financial Results

Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM
NURO

GlobeNewswire

a year ago

Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM

Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target
NURO

PR Newswire

a year ago

Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
NURO

GlobeNewswire

a year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

AmpliTech to Host Quarterly Investor Call to Review Q3 2023 Earnings on Tuesday November 14, 4:30 PM ET; Dial-in # 1-833-630-0019 or 1-412-317-1807
NURO

ACCESSWIRE

a year ago

AmpliTech to Host Quarterly Investor Call to Review Q3 2023 Earnings on Tuesday November 14, 4:30 PM ET; Dial-in # 1-833-630-0019 or 1-412-317-1807

Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile
NURO

GlobeNewswire

a year ago

Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript
NURO

Insider Monkey

a year ago

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Q3 2023 Earnings Call Transcript
NURO

Insider Monkey

a year ago

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Q3 2023 Earnings Call Transcript

LENSAR Reports Third Quarter 2023 Results and Provides Business Update
NURO

Business Wire

a year ago

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

Wilhelmina International (NASDAQ:WHLM) Is Looking To Continue Growing Its Returns On Capital
NURO

Simply Wall St.

a year ago

Wilhelmina International (NASDAQ:WHLM) Is Looking To Continue Growing Its Returns On Capital

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
NURO

GlobeNewswire

a year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

FKM Sintertechnik, One of Germany's Largest Service Providers for 3D Printed Parts, Invests in voxeljet's Large-format VX1000 HSS Polymer Printer
NURO

Business Wire

a year ago

FKM Sintertechnik, One of Germany's Largest Service Providers for 3D Printed Parts, Invests in voxeljet's Large-format VX1000 HSS Polymer Printer

Purple Biotech Fortifies NT219 Patent Protection
NURO

GlobeNewswire

a year ago

Purple Biotech Fortifies NT219 Patent Protection

Share on Social Networks: